| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $20.7M | +562.3% |
| R&D Expense | $97.1M | +21.0% |
| SG&A Expense | $36.5M | +10.9% |
| Operating Income | -$112.9M | -2.6% |
| Income Tax | $0 | — |
| Net Income | -$100.8M | +6.2% |
| EPS (Basic) | -$2.58 | +22.3% |
| EPS (Diluted) | -$2.58 | +22.3% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $249.1M | +375.8% |
| Short-term Investments | $39.1M | -75.7% |
| Current Assets | $296.6M | +34.5% |
| Total Assets | $339.9M | +29.8% |
| Current Liabilities | $19.0M | +20.5% |
| Total Liabilities | $32.1M | +5.1% |
| Stockholders' Equity | $307.8M | +33.1% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$75.8M | +12.6% |
| Capital Expenditures | $2.8M | -76.0% |
| Investing Cash Flow | $115.7M | +778.7% |
| Financing Cash Flow | $156.8M | +4983.7% |
| Free Cash Flow | -$78.6M | +20.0% |